MyoCon! Rate increases on August 28th!Promising Trial News from argenx and Abcuro The myositis community recently received encouraging news from two companies developing treatments for different forms of myositis. While much work remains before these…
Continue Reading
From Volcanic Soil to a Possible Treatment for IBM
By Nataliya Slater Our team in Australia is leading a clinical trial investigating sirolimus (rapamycin) as a potential treatment for inclusion body myositis (IBM). But do you know the remarkable…
Continue Reading
Seven Voices from the Myositis Community
The Myositis Association and Community Resonance Foundation Publish Myositis Issue of ENCORES Belfast, ME – August 2026 – What happens when a disease is difficult to recognize, difficult to diagnose,…
Continue Reading
Going the Distance for Dermatomyositis: Trail Update from the PCT
By Kaila Balch When I launched this journey in May, my goal was simple: hike the Pacific Crest Trail in honor of my cousin Brandon, who lives with dermatomyositis, while…
Continue Reading
A New Model for Understanding IBM
Each year, TMA awards research funding to support innovative investigations to improve understanding and treatment of myositis diseases. Dr. Thomas Lloyd recently completed such a project in which he and…
Continue Reading